Bio Path reported $-0.04 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.





Eps Change Date
Alterity Therapeutics Limited AUD 0 0 Dec/2025
Baxter International USD 0.56 0.2 Jun/2026
Bio Path USD -0.04 0.04 Mar/2026
Cipla INR 9.76 2.9 Jun/2026
Clal Biotechnology ILS -0.04 0.1 Dec/2022
Compugen USD -0.23 0.82 Mar/2026
CSL USD 5.07 3 Dec/2025
Grifols EUR 0.16 0.02 Mar/2026
Karyopharm Therapeutics USD -1.02 1.2 Mar/2026